MRNA expression of bone morphogenetic proteins and their receptors in human renal cell carcinoma

Urologia Internationalis

Volumn 87, Issue 3, 2011, Pages 353-358

  Markić, Dean ^a   Ćelić, Tanja ^b   Gršković, Antun ^a   Španjol, Josip ^a   Fučkar, Željko ^a   Grahovac, Blaženka ^c   Dordević, Gordana ^c   Bobinac, Dragica ^b  

^a KBC RIJEKA   (Croatia)

^b Department of Anatomy ^*  (Croatia)

^c UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Bone morphogenetic protein receptors; Bone morphogenetic proteins; Renal cell carcinoma; Reverse transcriptase polymerase chain reaction

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; MESSENGER RNA; OSTEOGENIC PROTEIN 1;

ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL;

ADULT; AGED; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEINS; CARCINOMA, RENAL CELL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; LIGANDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 80055062073     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000330797     Document Type: Article

References (30)

1. Chen D, Zhao M, Mundy GR: Bone morphogenetic proteins. Growth Factors 2004; 22: 233-241.
2. Simic P, Vukicevic S: Bone morphogenetic proteins in development and homeostasis of kidney. Cytokine Growth Factor Rev 2005; 16: 299-308.
3. Hahn GV, Cohen RB, Wozney JM, et al: A bone morphogenetic protein subfamily: Chromosomal localization of human genes for BMP5, BMP6, and BMP7. Genomics 1992; 14: 759-762.
4. Li B: Bone morphogenetic protein-SMAD pathway as drug targets for osteoporosis and cancer therapy. Endocr Metab Immune Disord Drug Targets 2008; 8: 208-219.
5. Miyazono K, Maeda S, Imamura T: BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling crosstalk. Cytokine Growth Factor Rev 2005; 16: 251-263.
6. Nohe A, Keating E, Knaus P, et al: Signal transduction of bone morphogenetic protein receptors. Cell Signal 2004; 16: 291-299.
7. Deng H, Makizumi R, Ravikumar TS, et al: Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells. Exp Cell Res 2007; 313: 1033-1044.
8. Langenfeld EM, Bojnowski J, Perone J, et al: Expression of bone morphogenetic proteins in human lung carcinomas. Ann Thorac Surg 2005; 80: 1028-1032.
9. Bobinac D, Maric I, Zoricic S, et al: Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer. Croat Med J 2005; 46: 389-396.
10. Alarmo EL, Rauta J, Kauraniemi P, et al: Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer. Genes Chromosomes Cancer 2006; 45: 411-419.
11. Darby S, Cross SS, Brown NJ, et al: BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype. J Pathol 2008; 214: 394-404.
12. Alarmo EL, Kuukasjärvi T, Karhu R, et al: A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7. Breast Cancer Res Treat 2007; 103: 239-246.
13. Kraunz KS, Nelson HH, Liu M, et al: Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer. Br J Cancer 2005; 93: 949-952.
14. Kwak C, Park YH, Kim IY, et al: Expression of bone morphogenetic proteins, the subfamily of the transforming growth factorbeta superfamily, in renal cell carcinoma. J Urol 2007; 178: 1062-1067.
15. Kim IY, Lee DH, Lee DK, et al: Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells. Clin Cancer Res 2003; 9: 6046-6051.
16. Basic-Jukic N, Radic-Antolic M, Hudolin T, et al: Immunolocalization and mRNA expression of bone morphogenetic protein-6 in human clear cell renal carcinoma. Kidney Blood Press Res 2009; 32: 445-450.
17. Markic D, Celic T, Spanjol J, et al: Expression of bone morphogenetic protein-7, its receptors and Smad1/5/8 in normal human kidney and renal cell cancer. Coll Antropol 2010; 34: 149-153.
18. Basic-Jukic N, Hudolin T, Radic-Antolic M, et al: Bone morphogenetic protein-7 expression is down-regulated in human clear cell renal carcinoma. J Nephrol 2011; 24: 91-97.
19. Jemal A, Tiwari RC, Murray T, et al: Cancer statistics, 2004. CA Cancer J Clin 2004; 54: 8-29.
20. Athar U, Gentile TC: Treatment options for metastatic renal cell carcinoma: A review. Can J Urol 2008; 15: 3954-3966.
21. Eble JN, Sauter G, Epstein JI, et al: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. World Health Organization Classification of Tumours. Lyons, IARC Press, 2004.
22. Patard JJ, Leray E, Rioux-Leclercq N, et al: Prognostic value of histological subtypes in renal cell carcinoma: A multicenter experience. J Clin Oncol 2005; 23: 2763-2771.
23. Borovecki F, Simic P, Grgurevic L, et al: The role of bone morphogenetic proteins in developing and adult kidney; in Vukicevic S, Sampath TK (eds): Bone Morphogenetic Proteins: Regeneration of Bone and Beyond. Basel, Birkhauser Verlag, 2004, pp 213-243.
24. Ozkaynak E, Schnegelsberg PN, Oppermann H: Murine osteogenic protein (OP-1): High levels of mRNA in kidney. Biochem Biophys Res Commun 1991; 179: 116-123.
25. Wetzel P, Haag J, Câmpean V, et al: Bone morphogenetic protein-7 expression and activity in the human adult normal kidney is predominantly localized to the distal nephron. Kidney Int 2006; 70: 717-723.
26. Feeley BT, Krenek L, Liu N, et al: Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Bone 2006; 38: 154-166.
27. Kang MH, Kim JS, Seo JE, et al: BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. Exp Cell Res 2010; 316: 24-37.
28. Langenfeld EM, Langenfeld J: Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2004; 2: 141-149.
29. Yuen HF, Chan YP, Cheung WL, et al: The prognostic significance of BMP-6 signaling in prostate cancer. Mod Pathol 2008; 21: 1436-1443.
30. Bosukonda D, Shih MS, Sampath KT, et al: Characterization of receptors for osteogenic protein-1/bone morphogenetic protein-7 (OP-1/BMP-7) in rat kidneys. Kidney Int 2000; 58: 1902-1911.